SCHEMBL29357464

SCHEMBL29357464

Cc1nn(C)c(C)c1-c1cccc2c1CC[C@H](N(C)C)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 18/20 1.00
HTR7 P34969 17/20 1.00
CHRM5 P08912 1/20 1.00
ADRA2A P08913 1/20 1.00
ADRA2B P18089 1/20 1.00
HTR1D P28221 1/20 1.00
HTR1B P28222 1/20 1.00
HTR3A P46098 1/20 1.00
HTR5A P47898 1/20 1.00
TMEM97 Q5BJF2 1/20 1.00
SIGMAR1 Q99720 1/20 1.00
HPGD P15428 1/20 1.00
DRD2 P14416 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3314221 1.00 HTR1A (1.00) HTR1AHTR7CHRM5ADRA2AADRA2B
SCHEMBL3316572 1.00 HTR1A (1.00) HTR1AHTR7CHRM5ADRA2AADRA2B
SCHEMBL273109 1.00 HTR1A (1.00) HTR1AHTR7CHRM5ADRA2AADRA2B
Hydrochloric Acid SCHEMBL3318115 0.99 HTR1A (0.98) HTR1AHTR7CHRM5ADRA2AADRA2B
Hydrochloric Acid SCHEMBL3318117 0.99 HTR1A (0.98) HTR1AHTR7CHRM5ADRA2AADRA2B
Hydrochloric Acid SCHEMBL3689173 0.99 HTR1A (0.98) HTR1AHTR7CHRM5ADRA2AADRA2B
Hydrochloric Acid SCHEMBL3689172 0.99 HTR1A (0.98) HTR1AHTR7CHRM5ADRA2AADRA2B
SCHEMBL3314497 0.89 HTR1A (0.80) HTR1AHTR7CHRM5ADRA2AADRA2B
SCHEMBL3319493 0.89 HTR1A (0.80) HTR1AHTR7CHRM5ADRA2AADRA2B
SCHEMBL3319496 0.89 HTR1A (0.80) HTR1AHTR7CHRM5ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025213239-A1 OPERATIONAL METHOD FOR MANAGING REVERSE LOGISTICS OF ELECTRICAL AND ELECTRONIC WASTE DEVOLVA GESTÃO INTEGRADA DE LOGÍSTICA REVERSA LTDA (BR) 2025-10-16 WO claimed
EP-4567112-A1 RNA INHIBITOR FOR INHIBITING APOC3 GENE EXPRESSION AND USE THEREOF Kylonova (Xiamen) Biopharma Co., Ltd. (CN) 2025-06-11 EP claimed
CN-119985733-A Method for measuring dibromohydantoin content in anastrozole starting material by ion chromatography 河北以岭医药研究院有限公司 2025-05-13 CN claimed
CN-119915940-A Liquid chromatography-inductively coupled plasma mass spectrometry combined detection method for arsenic form in urine 北京市疾病预防控制中心 2025-05-02 CN claimed
CN-114062519-B Method for separating and detecting dichloro-hydantoin 广东东阳光药业股份有限公司 2025-04-15 CN claimed
CN-119804694-A Method for measuring chloride ions in oil 武汉食品化妆品检验所 2025-04-11 CN claimed
WO-2025059012-A1 BIOSENSOR FOR RAPID DETECTION OF PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2025-03-20 WO claimed
CN-119555842-A Method for separating iodide and glyphosate in high-salt water by two-dimensional ion chromatography 中国环境监测总站 2025-03-04 CN claimed
CN-119510661-A Rapid detection method for trace chloride ions in synthetic silicon dioxide and application thereof 浙江大学杭州国际科创中心 2025-02-25 CN claimed
CN-109682651-B Portable collection device and detection method for chloride ions on surface of coastal building 上海交通大学 2025-01-17 CN claimed
CN-114994214-B Method for qualitatively detecting neutral oligosaccharide in breast milk 北京三元食品股份有限公司 2023-02-24 CN claimed
CN-115112799-A Method for qualitatively detecting acid oligosaccharide in breast milk 北京三元食品股份有限公司 2022-09-27 CN claimed
CN-112505190-B Method for detecting acrylic acid in soil 中煤浙江检测技术有限公司 2022-09-16 CN claimed
US-20220273680-A1 Methods of Treating Psychological and Brain Disorders UNIVERSITY OF MARYLAND, BALTIMORE (US) 2022-09-01 US claimed
CN-111077264-B Method for realizing switching use of double systems of single ion chromatograph 湖南金泰环保科技有限公司 2022-06-24 CN claimed
US-20220193082-A1 COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY ZOGENIX INTERNATIONAL LIMITED (GB) 2022-06-23 US claimed
CN-114599355-A Method for treating psychological and cerebral diseases 马里兰大学巴尔的摩分校 2022-06-07 CN claimed
CN-114527202-A Method for determining salt forming rate of methylergometrine maleate raw material 河北省药品医疗器械检验研究院(河北省化妆品检验研究中心) 2022-05-24 CN claimed
US-20220146492-A1 CELL MEMBRANE PERMEABILITY RESTORING THERAPY SHINE IAN BASIL (US) 2022-05-12 US claimed
CN-114062519-A Method for separating and detecting dichlorohydantoin 广东东阳光药业有限公司 2022-02-18 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193082-A1 COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY HTR2B, HTR3B, HTR5A HTR1A 6/4885HTR7 12/4885CHRM5 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.